Back to Journals » OncoTargets and Therapy » Volume 8

Using an innovative multiple regression procedure in a cancer population (Part I): detecting and probing relationships of common interacting symptoms (pain, fatigue/weakness, sleep problems) as a strategy to discover influential symptom pairs and clusters [Erratum] 

Authors Francoeur RB

Received 24 December 2014

Accepted for publication 24 December 2014

Published 23 January 2015 Volume 2015:8 Pages 241—242


Francoeur RB. OncoTargets Ther. 2015;8:45–56.

On page 45, Background section, line three, “diesease markers” should read “disease markers”.

Read the original article

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]


Readers of this article also read:

Experience with combination of nimotuzumab and intensity-modulated radiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma

Zhai RP, Ying HM, Kong FF, Du CR, Huang S, Zhou JJ, Hu CS

OncoTargets and Therapy 2015, 8:3383-3390

Published Date: 18 November 2015

Profile of blinatumomab and its potential in the treatment of relapsed/refractory acute lymphoblastic leukemia

Ribera JM, Ferrer A, Ribera J, Genescà E

OncoTargets and Therapy 2015, 8:1567-1574

Published Date: 24 June 2015

The prognostic significance of fibroblast growth factor receptor 4 in non-small-cell lung cancer

Huang H, Feng H, Qiao H, Ren Z, Zhu G

OncoTargets and Therapy 2015, 8:1157-1164

Published Date: 22 May 2015

Tumor heterogeneity in the recurrence of epithelial ovarian cancer demonstrated by polycomb group proteins

Gui T, Bai HM, Zeng JF, Zhong ZJ, Cao DY, Cui QC, Chen J, Yang JX, Shen K

OncoTargets and Therapy 2014, 7:1705-1716

Published Date: 25 September 2014

Retrospective study of threshold time for the conventional treatment of branch retinal artery occlusion

Muramatsu D, Minezaki T, Tsubota K, Wakabayashi Y, Goto H

Clinical Ophthalmology 2014, 8:1877-1881

Published Date: 22 September 2014

Clinicopathological and biological significance of aberrant activation of glycogen synthase kinase-3 in ovarian cancer

Fu Y, Wang X, Cheng X, Ye F, Xie X, Lu W

OncoTargets and Therapy 2014, 7:1159-1168

Published Date: 25 June 2014

Fabrication of nanoadjuvant with poly-e-caprolactone (PCL) for developing a single-shot vaccine providing prolonged immunity

Prashant CK, Bhat M, Srivastava SK, Saxena A, Kumar M, Singh A, Samim M, Ahmad FJ, Dinda AK

International Journal of Nanomedicine 2014, 9:937-950

Published Date: 12 February 2014